Chemomab Therapeutics Ltd. (CMMB)
2.59
-0.10
(-3.72%)
USD |
NASDAQ |
Sep 10, 16:00
2.59
0.00 (0.00%)
After-Hours: 20:00
Chemomab Therapeutics Shareholders Equity (Quarterly) : 8.685M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.685M |
| March 31, 2026 | 10.70M |
| December 31, 2025 | 12.33M |
| September 30, 2025 | 11.23M |
| June 30, 2025 | 9.699M |
| March 31, 2025 | 10.39M |
| December 31, 2024 | 13.54M |
| September 30, 2024 | 16.32M |
| June 30, 2024 | 9.985M |
| March 31, 2024 | 13.33M |
| December 31, 2023 | 17.00M |
| September 30, 2023 | 18.04M |
| June 30, 2023 | 21.99M |
| March 31, 2023 | 27.95M |
| December 31, 2022 | 36.22M |
| September 30, 2022 | 44.62M |
| June 30, 2022 | 51.84M |
| March 31, 2022 | 57.24M |
| December 31, 2021 | 61.47M |
| September 30, 2021 | 65.51M |
| June 30, 2021 | 68.04M |
| March 31, 2021 | 55.16M |
| December 31, 2020 | 3.577M |
| September 30, 2020 | 5.351M |
| June 30, 2020 | 8.157M |
| Date | Value |
|---|---|
| March 31, 2020 | 11.56M |
| December 31, 2019 | 14.91M |
| September 30, 2019 | 9.286M |
| June 30, 2019 | 24.88M |
| March 31, 2019 | 26.35M |
| December 31, 2018 | -1.09M |
| September 30, 2018 | 0.233M |
| June 30, 2018 | 2.587M |
| March 31, 2018 | -3.912M |
| December 31, 2017 | -0.609M |
| September 30, 2017 | 1.119M |
| June 30, 2017 | 2.905M |
| March 31, 2017 | 1.339M |
| December 31, 2016 | 3.293M |
| September 30, 2016 | 4.064M |
| June 30, 2016 | 0.8535M |
| March 31, 2016 | 1.43M |
| December 31, 2015 | 2.145M |
| September 30, 2015 | 3.320M |
| June 30, 2015 | 4.196M |
| March 31, 2015 | 6.754M |
| December 31, 2014 | 4.990M |
| September 30, 2014 | 6.783M |
| June 30, 2014 | 1.793M |
| March 31, 2014 | 3.028M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioLineRx Ltd. | 13.77M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 269.56M |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | 12.74M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.24M |
| Total Liabilities (Quarterly) | 1.553M |
| Current Ratio | 6.411 |
| Net Debt Paydown Yield | 0.50% |